26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

96<br />

Chapter | 4 Lipids and Ketones<br />

Barrie, 1993 ). The main lipid that is increased is cholesterol,<br />

but triacylglycerol may be increased too, and most <strong>of</strong><br />

the increased lipid is in LDL and HDL, but some animals<br />

have increased VLDL or chylomicron levels as well ( Rogers,<br />

1977 ; Whitney, 1992 ). The mechanism by which hypothyroidism<br />

causes hyperlipidemia in dogs is unknown; however,<br />

a similar phenomenon occurs in humans, and in that species,<br />

it appears that hypothyroidism decreases lipoprotein lipase<br />

and hepatic lipase activities ( Valdemarsson et al ., 1983 ). The<br />

prolonged hypercholesterolemia associated with chronic<br />

hypothyroidism in dogs may lead to atherosclerosis ( Liu<br />

et al ., 1986 ; Patterson et al ., 1985 ), although other factors<br />

may be involved as well.<br />

Dogs with naturally occurring pancreatitis frequently<br />

have hyperlipidemia ( Hardy, 1992 ; Whitney et al ., 1987 ).<br />

Because the pancreatitis in some <strong>of</strong> these animals causes<br />

diabetes, the hyperlipidemia in those individuals may be<br />

due to diabetes. Plasma lipid levels <strong>of</strong> dogs with pancreatitis<br />

induced by injecting bile into or ligating the pancreatic<br />

duct are comparable to control dogs (Bass, 1976; Whitney<br />

et al ., 1987 ; Zieve, 1968 ). In some cases, hyperlipidemia<br />

may play a role in the pathogenesis <strong>of</strong> pancreatitis rather<br />

than being a result <strong>of</strong> pancreatitis. This proposition is supported<br />

by the fact that humans with some forms <strong>of</strong> hyperlipidemia<br />

have increased risk <strong>of</strong> pancreatitis ( Cameron<br />

et al ., 1974 ; Greenberger, 1973 ). One proposed mechanism<br />

is that increased lipids, especially chylomicrons, entering<br />

the pancreatic capillaries will be hydrolyzed by pancreatic<br />

lipase, and the resultant LCFA may injure endothelial or<br />

acinar cells ( Havel, 1969 ). Once the initial damage occurs,<br />

there is a positive feedback in which more lipase enters<br />

the circulation and hydrolyses more triacylglycerol leading<br />

to more LCFA release and more damage. In support<br />

<strong>of</strong> this theory, when dog pancreata were perfused with a<br />

medium containing high levels <strong>of</strong> triacylglycerol or LCFA,<br />

they became edematous and hemorrhagic and released<br />

large amounts <strong>of</strong> amylase compared to pancreata perfused<br />

without these additions ( Saharia et al ., 1977 ). In a related<br />

proposed mechanism, large amounts <strong>of</strong> chylomicrons or<br />

VLDL may impede the microcirculation <strong>of</strong> the pancreas,<br />

leading to partial stasis, which allows blood lipids and their<br />

hydrolysis products more contact with pancreatic cells<br />

( Hardy, 1992 ).<br />

Dogs with uncontrolled diabetes frequently have hyperlipidemia<br />

( Medaille et al ., 1988 ; Rogers, 1977 ; Whitney,<br />

1992 ). In naturally occurring cases, plasma triacylglycerol<br />

levels are increased with concomitant increases in VLDL<br />

levels and <strong>of</strong>ten hyperchylomicronemia is present as well<br />

( DeBowes, 1987 ; Ford, 1995 ; Rogers, 1977 ; Rogers et al .,<br />

1975b ). The increase in VLDL is due in part to increased<br />

mobilization <strong>of</strong> LCFA from adipose. The liver removes<br />

LCFA from plasma and reissues some <strong>of</strong> them to the<br />

plasma as triacylglycerol in VLDL. In addition, synthesis <strong>of</strong><br />

lipoprotein lipase by peripheral tissues is partially dependent<br />

on insulin, so less <strong>of</strong> this enzyme is available to remove triacylglycerol<br />

from the circulation ( Brown and Goldstein, 1994 ).<br />

Hyperlipidemia with increases in plasma triacylglycerol<br />

and cholesterol levels have been noted in dogs with cholestasis<br />

( Bauer et al ., 1989 ; Meyer and Chiapella, 1985 ).<br />

The increase in cholesterol can be explained in part by the<br />

inability <strong>of</strong> the liver to remove and catabolize cholesterol.<br />

However, there is evidence <strong>of</strong> production <strong>of</strong> an abnormal<br />

LDL, called lipoprotein-X, which is rich in cholesterol<br />

( Bauer et al ., 1989 ; Blomh<strong>of</strong>f et al ., 1978 ; Danielsson<br />

et al ., 1977 ; Meyer and Chiapella, 1985 ).<br />

Dogs with hyperadrenocorticism (Cushing’s disease)<br />

<strong>of</strong>ten have hyperlipidemia with increased total plasma cholesterol<br />

levels ( Barrie et al ., 1993 ; Feldman, 1995 ; Ling<br />

et al ., 1979 ; Medaille et al ., 1988 ; Scott, 1979 ). Most <strong>of</strong> the<br />

increased plasma cholesterol is associated with LDL, and<br />

although the mechanism <strong>of</strong> the hyperlipidemia is unclear,<br />

it may be related to a decrease in activity <strong>of</strong> hepatic LDL<br />

receptors ( Barrie et al ., 1993 ).<br />

Dogs with nephrotic syndrome <strong>of</strong>ten have hyperlipidemia<br />

( Ford, 1995 ; Lewis and Center, 1984 ; McCullagh,<br />

1978 ; Medaille et al ., 1988 ). Hypercholesterolemia is<br />

present most commonly, but hypertriacylglycerolemia<br />

may be present as well, especially in more severe cases<br />

( McCullagh, 1978 ). In humans with nephrotic syndrome,<br />

the hyperlipidemia appears to be related to the loss <strong>of</strong><br />

albumin or regulatory factors in the urine, and infusion <strong>of</strong><br />

albumin or dextran into afflicted patients lowers lipid levels<br />

( Glassock et al ., 1991 ). Albumin or regulatory factors<br />

may inhibit VLDL production by the liver, and without<br />

this inhibition, more VLDL will be released to the plasma<br />

increasing VLDL and LDL levels ( Glassock et al ., 1991 ).<br />

Idiopathic hyperlipidemia, which is probably inherited,<br />

occurs in some miniature schnauzers ( Ford, 1993 ;<br />

Richardson, 1989 ; Rogers et al ., 1975a ). <strong>Animals</strong> present<br />

with abdominal pain, diarrhea, and vomiting, and sometimes<br />

with seizures and pancreatitis. Affected animals<br />

have hypertriacylglycerolemia, hypercholesterolemia, and<br />

increased chylomicron levels and <strong>of</strong>ten have increased levels<br />

<strong>of</strong> other lipoproteins as well. The animals <strong>of</strong>ten have<br />

elevated liver enzymes as well (Xenoulis et al ., 2008). It<br />

has been proposed that these animals may have low levels<br />

<strong>of</strong> lipoprotein lipase or perhaps deficient apolipoprotein<br />

C-II, the activator <strong>of</strong> lipoprotein lipase. However, some<br />

dogs have shown clearing <strong>of</strong> the plasma following heparin<br />

injection, so the mechanism remains unknown. The primary<br />

treatment is to place the animal on a low-fat diet. A<br />

similar syndrome has been reported in mixed-breed dogs<br />

( Baum et al ., 1969 ; Rogers et al ., 1975a ) and in Brittany<br />

spaniels ( Hubert et al ., 1987 ). Hypercholesterolemia, which<br />

is probably inherited, has been reported in rough collie<br />

dogs ( Jeusette et al ., 2004 ) and Shetland sheepdogs ( Sato<br />

et al ., 2000 ). Corneal lipidosis, which responded to<br />

dietary manipulation, was observed in the former, and

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!